Home » Superbugs Spur FDA, Drug Firms to Action: Baxter Gets OK to Sell MRSA-Blocking device; Agency Speeds Reviews
Superbugs Spur FDA, Drug Firms to Action: Baxter Gets OK to Sell MRSA-Blocking device; Agency Speeds Reviews
As the bacterium MRSA becomes more widespread, the federal government and the drug and medical-device industries are recognizing the need to speed up the fight to combat superbugs, in what could be a multibillion-dollar market for tests, products and pharmaceuticals.
Trading Markets
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May